Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

N/ARecruitingNCT06930677

Next Biomedical Co., Ltd.72 enrolled

Overview

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Knee Osteoarthritis (Knee OA)

Interventions

embolization therapyDEVICE

MSK embolization

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Osteoarthritis proven by MR-imaging Exclusion Criteria: * Current local infection * Life expectancy less than 6 months

Locations (3)

University Hospital Ghent

Ghent, Belgium

RECRUITING

Uz Leuven

Leuven, Belgium

RECRUITING

Elisabeth-Tweesteden Hospital

Tilburg, Netherlands

RECRUITING

Outcomes

Primary Outcomes

Knee Injury and Osteoarthritis Outcome score (KOOS-12)

Knee Injury and Osteoarthritis Outcome score (KOOS-12) is to evaluate the pain, function and quality of life. The total score ranges from 0 to 100, where higher scores indicate better outcomes.

Time frame: 6 months post treatment

Secondary Outcomes

Visual Analog Scale(VAS)

Visual Analog Scale(VAS) is to evaluate the pain from 0 to 10. Higher scores indicate worse outcomes, representing more severe pain

Time frame: 6 months post treatment

Whole Organ Magnetic Resonance Imaging Score (WORMS)

Whole Organ Magnetic Resonance Imaging Score (WORMS) is a semi-quantitative scoring method for multi-feature, whole-organ evaluation of knee OA based on MRI. The total score ranges from 0 to 332, with higher scores indicating worse outcomes.

Time frame: 6 months post treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.